ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 135 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $277,620 | +23.4% | 8,400 | +71.4% | 0.00% | +50.0% |
| Q1 2022 | $225,000 | -30.8% | 4,900 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $325,000 | -18.8% | 4,900 | -23.4% | 0.00% | -50.0% |
| Q3 2021 | $400,000 | -51.7% | 6,400 | -36.0% | 0.00% | -50.0% |
| Q2 2021 | $828,000 | +22.5% | 10,000 | -2.0% | 0.01% | +14.3% |
| Q1 2021 | $676,000 | -16.9% | 10,200 | -3.8% | 0.01% | -22.2% |
| Q4 2020 | $813,000 | +38.7% | 10,600 | -22.1% | 0.01% | +28.6% |
| Q3 2020 | $586,000 | -27.8% | 13,600 | -27.7% | 0.01% | -30.0% |
| Q2 2020 | $812,000 | +168.9% | 18,800 | +79.0% | 0.01% | +150.0% |
| Q1 2020 | $302,000 | -20.7% | 10,500 | +75.0% | 0.00% | 0.0% |
| Q4 2019 | $381,000 | -37.5% | 6,000 | -73.9% | 0.00% | -42.9% |
| Q2 2019 | $610,000 | +56.0% | 23,000 | +8.0% | 0.01% | +40.0% |
| Q1 2019 | $391,000 | -6.5% | 21,300 | -2.3% | 0.01% | 0.0% |
| Q3 2018 | $418,000 | – | 21,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |